On Tuesday, Dynavax Technologies Corp (NASDAQ: DVAX) opened higher 2.82% from the last session, before settling in for the closing price of $10.3. Price fluctuations for DVAX have ranged from $9.22 to $14.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -305.00% at the time writing. With a float of $114.40 million, this company’s outstanding shares have now reached $123.70 million.
In an organization with 405 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 82.27%, operating margin of -3.1%, and the pretax margin is -18.85%.
Dynavax Technologies Corp (DVAX) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Dynavax Technologies Corp is 4.73%, while institutional ownership is 103.31%. The most recent insider transaction that took place on Mar 24 ’25, was worth 140,000. In this transaction President & COO of this company sold 10,000 shares at a rate of $14.00, taking the stock ownership to the 8,078 shares. Before that another transaction happened on Mar 24 ’25, when Company’s Officer proposed sale 10,000 for $14.00, making the entire transaction worth $140,000.
Dynavax Technologies Corp (DVAX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -305.00% per share during the next fiscal year.
Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators
Check out the current performance indicators for Dynavax Technologies Corp (DVAX). In the past quarter, the stock posted a quick ratio of 10.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.32. Likewise, its price to free cash flow for the trailing twelve months is 23.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.53 in one year’s time.
Technical Analysis of Dynavax Technologies Corp (DVAX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.4 million. That was inferior than the volume of 2.23 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 84.06%.
During the past 100 days, Dynavax Technologies Corp’s (DVAX) raw stochastic average was set at 25.32%, which indicates a significant decrease from 87.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.36 in the past 14 days, which was lower than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.17, while its 200-day Moving Average is $11.86. However, in the short run, Dynavax Technologies Corp’s stock first resistance to watch stands at $10.80. Second resistance stands at $11.02. The third major resistance level sits at $11.30. If the price goes on to break the first support level at $10.30, it is likely to go to the next support level at $10.02. Assuming the price breaks the second support level, the third support level stands at $9.80.
Dynavax Technologies Corp (NASDAQ: DVAX) Key Stats
There are currently 120,081K shares outstanding in the company with a market cap of 1.27 billion. Presently, the company’s annual sales total 277,250 K according to its annual income of 27,310 K. Last quarter, the company’s sales amounted to 68,160 K and its income totaled -96,100 K.
